Search results
Author(s):
Stephen J Greene
Added:
1 year ago
ESC-HFA 23 — Dr Stephen Greene (Duke University School of Medicine, US) outlines the findings from the QoL study of the TRANSFORM-HF Trial (NCT03296813).
The TRANSFORM-HF trial is a randomized trial which compared torsemide to furosemide as a treatment for patients with heart failure. Around 2859 patients with heart failure were enrolled in the trial, whose clinical outcomes were measured across…
View more
Author(s):
Ross Campbell
Added:
1 year ago
ESC-HFA 23 –Dr Ross Campbell (University of Glasgow, UK)joins us onsite to discuss the findings of the DAPA-RESIST Trial, which aimed to assess the affect of dapagliflozin as compared to metolazone in heart failure patients with diuretic resistance (NCT04860011).
In this phase 3 trial, investigators studied whether SGLT2i led to greater diuresis in this patient group, as to the standard practice…
View more
Author(s):
Harriette Van Spall
,
James L Januzzi
Added:
1 year ago
ESC-HFA 2023 – Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) joined by Dr James Januzzi (Massachusetts General Hospital, US) to discuss late-breaking science highlights of this year's ESC Heart Failure.
Trials covered in details include:
1:13: First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy
1:42: TRACER-HF:Trientine-HCL for treatment of…
View more
Author(s):
Jelena Celutkiene
,
Alexandre Mebazaa
,
Jan Biegus
,
et al
Added:
1 week ago
Author(s):
Rafael de la Espriella
,
Gonzalo Núñez-Marín
,
Pau Codina
,
et al
Added:
1 year ago
Author(s):
Cinzia Nugara
,
Francesco Giallauria
,
Giuseppe Vitale
,
et al
Added:
1 year ago
Author(s):
Laibah Arshad Khan
,
Adeena Jamil
,
Stephen J Greene
,
et al
Added:
1 month ago